Identifying patients at risk: multi‐centre comparison of HeartMate 3 and HeartWare left ventricular assist devices
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14308
Abstract: Since the withdrawal of HeartWare (HVAD) from the global market, there is an ongoing discussion if and which patients require prophylactically exchange for a HeartMate 3 (HM3). Therefore, it is important to study outcome differences… read more here.
Keywords: risk multi; identifying patients; multi centre; patients risk ... See more keywords
Stroke and Intracranial Hemorrhage in HeartMate II and HeartWare Left Ventricular Assist Devices: A Systematic Review
Sign Up to like & getrecommendations! Published in 2017 at "Neurocritical Care"
DOI: 10.1007/s12028-017-0386-7
Abstract: AbstractBackgroundIschemic stroke and intracranial hemorrhage (ICH) following left ventricular assist device (LVAD) placement are major causes of morbidity. The incidence and mortality associated with these events stratified by device type have not been systematically explored.MethodsA… read more here.
Keywords: range; intracranial hemorrhage; stroke intracranial; mortality ... See more keywords
Evolution of thrombolytic therapy in patients with HeartWare ventricular assist device thrombosis: a single-institutional experience
Sign Up to like & getrecommendations! Published in 2022 at "Interactive Cardiovascular and Thoracic Surgery"
DOI: 10.1093/icvts/ivac054
Abstract: Abstract OBJECTIVES Pump thrombosis remains a major challenge in heart failure patients with left ventricular HeartWare assist device. Current International Society for Heart and Lung Transplantation recommendations favour surgical pump exchange over lysis because safety… read more here.
Keywords: device thrombosis; therapy; heartware; assist device ... See more keywords
Adverse Event Rates Change Favorably Over Time for Patients Bridged With the HeartWare Left Ventricular Assist Device
Sign Up to like & getrecommendations! Published in 2017 at "ASAIO Journal"
DOI: 10.1097/mat.0000000000000585
Abstract: The HeartWare Ventricular Assist System (HVAD) provides significant improvements in survival and quality of life, and here, we seek to evaluate temporal differences in the adverse event (AE) rates. Patients (n = 382) in the… read more here.
Keywords: adverse event; time; event rates; heartware ... See more keywords
Advantages and disadvantages of using intravenous tissue Plasminogen activator as salvage therapy for inoperable HeartWare thrombosis
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cardiac Surgery"
DOI: 10.1111/jocs.13165
Abstract: Device thrombosis is a devastating complication of left ventricular assist devices. The definitive treatment has been device exchange or explant. Evidence of increasing morbidity and mortality with device exchange has shifted strategies toward conservative management.… read more here.
Keywords: heartware; salvage therapy; thrombosis; device ... See more keywords